Kexin Liu

2.8k total citations
85 papers, 2.3k citations indexed

About

Kexin Liu is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Kexin Liu has authored 85 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 24 papers in Pharmacology and 13 papers in Oncology. Recurrent topics in Kexin Liu's work include Drug-Induced Hepatotoxicity and Protection (13 papers), Drug Transport and Resistance Mechanisms (10 papers) and Liver physiology and pathology (8 papers). Kexin Liu is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (13 papers), Drug Transport and Resistance Mechanisms (10 papers) and Liver physiology and pathology (8 papers). Kexin Liu collaborates with scholars based in China, Japan and United States. Kexin Liu's co-authors include Qiang Meng, Changyuan Wang, Huijun Sun, Yue Jin, Zhihao Liu, Jinyong Peng, Lina Xu, Yan Qi, Youwei Xu and Yan Tian and has published in prestigious journals such as The Science of The Total Environment, Hepatology and Journal of Agricultural and Food Chemistry.

In The Last Decade

Kexin Liu

80 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kexin Liu China 29 837 488 289 282 282 85 2.3k
Pengyuan Sun China 29 936 1.1× 524 1.1× 443 1.5× 575 2.0× 125 0.4× 89 2.3k
Abeer Salama Egypt 30 625 0.7× 266 0.5× 185 0.6× 142 0.5× 248 0.9× 165 2.8k
Jingjing Wu China 27 918 1.1× 547 1.1× 185 0.6× 325 1.2× 182 0.6× 98 2.2k
Ashraf B. Abdel‐Naim Egypt 37 1.3k 1.6× 540 1.1× 254 0.9× 395 1.4× 222 0.8× 168 4.2k
Nemat Ali Saudi Arabia 29 961 1.1× 518 1.1× 156 0.5× 273 1.0× 210 0.7× 201 3.2k
Joydeep Das India 20 971 1.2× 410 0.8× 225 0.8× 181 0.6× 121 0.4× 39 2.9k
Ravirajsinh N. Jadeja United States 31 985 1.2× 417 0.9× 334 1.2× 147 0.5× 111 0.4× 102 3.2k
Longfei Lin China 19 776 0.9× 495 1.0× 199 0.7× 274 1.0× 130 0.5× 76 2.4k
Jingyuan Wan China 38 1.3k 1.6× 636 1.3× 430 1.5× 346 1.2× 185 0.7× 112 3.5k
Hany H. Arab Egypt 34 1.1k 1.3× 406 0.8× 252 0.9× 233 0.8× 110 0.4× 87 3.1k

Countries citing papers authored by Kexin Liu

Since Specialization
Citations

This map shows the geographic impact of Kexin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kexin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kexin Liu more than expected).

Fields of papers citing papers by Kexin Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kexin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kexin Liu. The network helps show where Kexin Liu may publish in the future.

Co-authorship network of co-authors of Kexin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Kexin Liu. A scholar is included among the top collaborators of Kexin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kexin Liu. Kexin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xue, Xiaohong Li, Yuan Tian, et al.. (2025). Completely conserved VP2 residue K140 of KREMEN1-dependent enteroviruses is critical for virus-receptor interactions and viral infection. mBio. 16(2). e0304024–e0304024. 2 indexed citations
2.
Gao, Fei, Tao Han, Xiaolong Yuan, et al.. (2025). Food-grade Lactococcus lactis expressing LEK peptide ameliorates hypertension and hyperlipidemia via ACE inhibition and lipid metabolism regulation. Journal of Functional Foods. 129. 106830–106830.
4.
Liu, Kexin, et al.. (2024). Sodium humate ameliorates LPS-induced liver injury in mice by inhibiting TLR4/NF-κB and activating NRF2/HO-1 signaling pathways. Molecular Biology Reports. 51(1). 204–204. 5 indexed citations
5.
Liu, Kexin, Yajun Chen, Kaizhi Huang, et al.. (2024). Resource Allocation for STAR-RIS-Assisted MIMO Physical-Layer Key Generation. IEEE Transactions on Information Forensics and Security. 19. 10328–10338. 10 indexed citations
6.
7.
Li, Xue, Yuan Tian, Kexin Liu, et al.. (2023). VP2 residue N142 of coxsackievirus A10 is critical for the interaction with KREMEN1 receptor and neutralizing antibodies and the pathogenicity in mice. PLoS Pathogens. 19(10). e1011662–e1011662. 3 indexed citations
8.
Jiang, Qinghua, et al.. (2021). Diterpenoid alkaloids from Delphinium forrestii var. viride and their anti-inflammation activity. Phytochemistry. 192. 112971–112971. 15 indexed citations
9.
Wang, Changyuan, Yue Jin, Qiang Meng, et al.. (2018). Activating the PGC‐1α/TERT Pathway by Catalpol Ameliorates Atherosclerosis via Modulating ROS Production, DNA Damage, and Telomere Function: Implications on Mitochondria and Telomere Link. Oxidative Medicine and Cellular Longevity. 2018(1). 2876350–2876350. 52 indexed citations
10.
Zhang, Shenghao, Mingxin Wang, Yuxuan Li, et al.. (2018). Action Video Games Influence on Audiovisual Integration in Visual Selective Attention Condition. 2 indexed citations
11.
Gao, Xiaoguang, Changyuan Wang, Kexin Liu, et al.. (2018). Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity. European Journal of Pharmacology. 824. 64–71. 21 indexed citations
12.
Wang, Changyuan, Zhihao Liu, Yaoting Sun, et al.. (2017). A stronger reversal effect of the combination of dasatinib and menadione on P-gp-mediated multidrug resistance in human leukemia K562/Adr cell line. RSC Advances. 7(28). 17227–17235. 3 indexed citations
13.
Wang, Changyuan, Yue Jin, Qiang Meng, et al.. (2017). Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK/NOX4/PI3K/AKT pathway. Pharmacological Research. 130. 466–480. 190 indexed citations
14.
Jin, Yue, Kexin Liu, Jinyong Peng, et al.. (2014). Rhizoma Dioscoreae Nipponicae polysaccharides protect HUVECs from H2O2-induced injury by regulating PPARγ factor and the NADPH oxidase/ROS–NF-κB signal pathway. Toxicology Letters. 232(1). 149–158. 43 indexed citations
15.
Liu, Kexin, Pengyuan Sun, Lin Mei, et al.. (2013). Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestane. Journal of Microencapsulation. 30(5). 432–440. 29 indexed citations
16.
Zhang, Shuai, Binan Lu, Xu Han, et al.. (2012). Protection of the flavonoid fraction from Rosa laevigata Michx fruit against carbon tetrachloride-induced acute liver injury in mice. Food and Chemical Toxicology. 55. 60–69. 96 indexed citations
17.
Ding, Pingtian, Lin Mei, Dongyan Gao, et al.. (2011). Effect of pH, vehicles and chemical enhancers on the skin permeation of loratadine. Latin American Journal of Pharmacy. 2 indexed citations
18.
Zhang, Yangqing, Leilei Sun, Cunxian Song, et al.. (2009). A novel paclitaxel-loaded poly(ε-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment. Acta Biomaterialia. 6(6). 2045–2052. 125 indexed citations
19.
Sun, Changkai, Guozhu Han, Jinyong Peng, et al.. (2009). Protective effect of tea polyphenols against paracetamol-induced hepatotoxicity in mice is significanly correlated with cytochrome P450 suppression. World Journal of Gastroenterology. 15(15). 1829–1829. 47 indexed citations
20.
Mei, Lin, Yangqing Zhang, Yi Zheng, et al.. (2009). A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment. Nanoscale Research Letters. 4(12). 1530–9. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026